Advantage of autologous blood transfusion in surgery for hepatocellular carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 32

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

314

HTML

2814

Figures (1-2)

299

Tables (1-5)

235

Sum=3662

Aug 28, 2011 (publication date) through Dec 22, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Aug 28, 2011; 17(32): 3709-3715
Published online Aug 28, 2011. doi: 10.3748/wjg.v17.i32.3709

Table 3 Results of multivariate logistic regression analysis for the need for homologous blood transfusion

		OR	95% CI	P-value
AT administration	±	28.571	9.615-83.333	< 0.0001
Maximum tumor size (cm)	< 5/≥ 5	1.126	0.500-2.538	0.774
Procedure	Nonanatomical/anatomical	1.016	0.449-2.202	0.967
Operation time (min)	< 300/≥ 300	0.986	0.435-2.242	0.974
Resected liver volume (g)	< 200/≥ 200	2.532	1.062-6.061	0.036
Intraoperative blood loss (mL)	< 2000/≥ 2000	30.303	9.346-100.000	< 0.0001

OR: Odds ratio; CI: Confidence interval; AT: Autologous transfusion.

Citation: Tomimaru Y, Eguchi H, Marubashi S, Wada H, Kobayashi S, Tanemura M, Umeshita K, Doki Y, Mori M, Nagano H. Advantage of autologous blood transfusion in surgery for hepatocellular carcinoma. World J Gastroenterol 2011; 17(32): 3709-3715
URL: https://www.wjgnet.com/1007-9327/full/v17/i32/3709.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i32.3709